Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, UT
Type II Diabetes- Patients currently taking Metformin
Type II diabetes accounts for more than 90% of the total number of diabetes cases. This disease is diagnosed by increased blood glucose (sugar) levels and the body’s inability to secrete adequate insulin to maintain normal blood glucose levels. As physicians, we understand the frustration some patients have with their diabetes. For this reason, our office has chosen to be part of a medical research study evaluating the safety and effectiveness of an investigational medication to see if it helps better control Type 2 diabetes than current medications.If it is determined that you are eligible for the study, you will be asked to come to our office every 4 to 6 weeks over a 3-year period. During these visits, various medical tests and evaluations will be performed to determine your safety and progress throughout the study. Qualified patients will receive study-related medical evaluations and study medication at no cost.
Individuals may be eligible to participate in the study if they:
Patient Exclusion Criteria: Hgb A1c- less than 7 or greater than 10 (will be determined at study visit)
Date Last Changed:
July 24, 2013
Jonna Nash, Study CoordinatorGranger Medical Research3725 West 4100 SouthWest Valley City, UT 84120Phone: 801-965-3765
Research Center Information: Granger Medical Research
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.